|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: AQUISTAR VENTURES USA INC, 10KSB/A, 2000-10-17 |
Next: MIVI BIOMEDICAL TECHNOLOGY, 10QSB, 2000-10-17 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-END> JUN-30-2000
<CASH> 1,299
<SECURITIES> 0
<RECEIVABLES> 423
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 1,722
<PP&E> 13,828
<DEPRECIATION> 0
<TOTAL-ASSETS> 15,550
<CURRENT-LIABILITIES> 78,821
<BONDS> 0
0
0
<COMMON> 350,909
<OTHER-SE> (414,080)
<TOTAL-LIABILITY-AND-EQUITY> (63,271)
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> (47,147)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (47,147)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (47,147)
<EPS-BASIC> (0.01)
<EPS-DILUTED> (0.01)
</TABLE>
|
|